E-Newsletter       I       Spring/Summer Issue       I       2021
In This Issue
News & Updates
Featured Vendors
Quick Links

Email Archive


Member Communications  

allows you to view recent emails sent by CCPAPP to members  

(Username and password required).

Updates to Your Practice?  
Please help us keep our membership information current by providing us with any updates regarding your address, phone, fax, or staff. Members may update information by logging onto our website and clicking on the applicable section(s) under My Account or by returning our Update to Existing Practice or Physician Information Form found on the Vendor Forms page of our website.
Refer a Practice
Contact Us
Dear CCPA Purchasing Partners (CCPAPP) Members, 
Our organization has many updates as well as reminders to share with you in this edition of our e-newsletter. Click on the links below or scroll to each section to learn more: 

News & Updates 
We hope you continue to enjoy the many savings and benefits offered by our program. Please contact a member of our staff at any time with questions, comments or feedback regarding our organization! 
CCPA Purchasing Partners, LLC

News & Updates
Register Today: Discount Now Available for Pfizer's Prevnar 13!Anchor1
CCPAPP and Pfizer are pleased to announce the addition of Pfizer's Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to the CCPAPP-Pfizer agreement! CCPAPP members will be eligible to receive a 2% discount on Prevnar 13. 

To access your Prevnar 13 discount:
  • Download the registration instructions here.
  • Begin the self-registration on Pfizer's Prime Contracts website
CCPAPP members will also need to complete CCPAPP's Vaccine Contracting and Compliance Form and submit it to info@ccpapp.org. CCPAPP Members who are already participating in the CCPAPP-Pfizer contract for Trumenba will not need to resubmit the CCPAPP Vaccine Contracting and Compliance Form. 

To place an order, members can do so directly through Pfizer Prime Vaccines at www.primevaccines.pfizer.com. Members who have never ordered online with Pfizer, will need to register on Pfizer Prime Vaccines. Please review the Pfizer Prime Quick Reference Guide for more information on ordering online. Members can also contact their Pfizer Vaccines Territory Manager or call Pfizer Customer Service at 1.800.666.7248 with any questions. 

VAXELIS™: A New Combination Vaccine by Merck and Sanofi PasteurAnchor4
VAXELIS is the first-and-only hexavalent vaccine approved by the FDA and will be available in June 2021. VAXELIS is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib). VAXELIS is approved for use as a three dose series in children six weeks through four years of age (prior to the fifth birthday).

Please review the VAXELIS Flashcard for more information. Additionally, before administering VAXELIS, please read the Prescribing Information and the Patient Information

To order VAXELIS, please visit www.VaccineShoppe.com.

For additional information on VAXELIS, please contact your Sanofi Pasteur Vaccine Representative or call Sanofi Pasteur at 800.VACCINE (800.822.2463). For any further questions, please contact Paresh Patel, Director of Operations, at 312.227.7436 or papatel@ccpapp.org.

The Pandemic Impact on Wellness Visits and Vaccinations for Children and AdolescentsAnchor2
The time for vaccine catch-up is now. Due to the COVID-19 pandemic, numerous reports have documented a drop in vaccination and prevention services. All age cohorts have seen a decrease in wellness visits during the pandemic, with the adolescent age cohorts being the most impacted. Summertime is a peak time period for children and adolescents to complete wellness visits and receive their routinely recommended vaccinations before or at the start of the school year. Read more.

Merck Resources on Vaccination Gaps and Reminding Parents About VaccinationsAnchor3
In 2020, the CDC's Advisory Committee on Immunization Practices (ACIP) strengthened its Hepatitis A catch-up recommendations to help close the vaccination gaps across the United States. Low Hepatitis A completion rates across the United States highlight the importance of vaccinating appropriate patients. To view the data, click here.

For suggestions that health care professionals and practices can consider to help improve their vaccination programs and increase their vaccination rates, please review this checklist provided by Merck.

COVID-19 Vaccination Communication ToolkitAnchor0
The CDC has put together a COVID-19 Vaccination toolkit that is intended to promote vaccine confidence among healthcare providers. Practices can use these materials to educate and build confidence in COVID-19 vaccination, raise awareness about the benefits of vaccination, and address common questions and concerns. To access the toolkit, click here

Featured Vaccine and Vendor Partners
Don't Forget: Book your FluMist Today!Anchor9

Remember to book your FluMist Quadrivalent from AstraZenenca! CCPAPP members will get a 5% discount off list price and FluMist purchases are eligible to be included in the calculation of your practice's annual administrative award distribution from CCPAPP.

Product and pricing information for CCPAPP's agreement with AstraZeneca can be found on the Vaccine and Vendor Pricing page of our website. You will need your practice's username and password in order to view the information. 

Orders must be placed through McKesson or another authorized distributor for AstraZeneca. As a preferred vendor and valued business partner of CCPAPP, we encourage all members to order through McKesson. If you currently do not have a McKesson ordering account, please feel free to contact CCPAPP or McKesson for assistance. A McKesson new account application can also be found on our Vaccine and Vendor Forms page. Please be advised that the DEA number provided to your distributor ordering account must match the DEA number associated with your practice's address.

Should you have any questions, please contact Tracey Ginger, Vaccine Business Manager for AstraZeneca, at 402.297.4457 or tracey.ginger@astrazeneca.com. Members can also contact AstraZeneca's Customer Service at
877.FLU.MIST (877.358.6478)

Let McKesson Help Your Practice Navigate Through COVID-19 Anchor10
McKesson Logo

To help practices as they navigate through COVID-19, McKesson has created a roadmap full of resources, articles, webinars and more, all around topics  important to the new state of healthcare. Click here for more information. To shop PPE and more, click here.

CCPAPP would like to remind members that there are various products and services provided by Staples to meet all of your office needs including products that support vaccine awareness. View available products here.  

                                  McKesson Logo    

Please note: Your email address is used by CCPA Purchasing Partners (CCPAPP) only for the purpose of sending out important communications. Email addresses are not shared with anyone outside of CCPAPP including our own partner vendors. We ask that your practice provides CCPAPP with at least one valid email address to ensure that you are in receipt of the information. If the email address to which this communication was sent should be updated, please respond to this email and include your practice name, the email address that should be removed from this distribution, and an updated email address to be added to our distribution. Thank you!

This message contains confidential information that is intended only for members of CCPA Purchasing Partners, LLC (CCPAPP). You should not disseminate or distribute this e-mail to anyone who is not a confirmed current member of CCPAPP. Please notify CCPAPP immediately if you have received this e-mail in error, and delete this e-mail from your system. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. CCPAPP therefore does not accept liability for any errors or omissions in the contents of this message which arise as a result of e-mail transmission. If verification is required please request a hard-copy version.